From Implementer to Influencer


CPOs are facing added pressures as they navigate the people side of business transformation. This report by Criticaleye Partner LACE Partners looks at HR’s role in business transformation, the challenges CPOs face and strategies to lead change effectively.

Key takeaways include:

  • 53 percent of C-Suite leaders say the most common point at which HR is brought into business transformation is when implementation planning begins
  • 85 percent of non-HR leaders rate the CPO’s influence in shaping the business transformation agenda as high
  • In 62 percent of companies surveyed, the CEO reports having regular contact with the CPO

Share this with your Community




Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

Cybersecurity Risk Oversight: A Governance Guide for Board Directors

Cyber risk has shifted from a technical issue to a core business threat. This report by CrowdStrike offers practical guidance to help Boards strengthen oversight and define what 'good' looks like. Key takeawa...


Click here to download this insight

Securing AI Systems: A Playbook for Security Leaders

Artificial intelligence is transforming the enterprise. This report by CrowdStrike explores what practical steps organisations can take to identify, assess and reduce AI-related exposure. Key takeaways include: ...


Click here to download this insight

2026 Global Threat Report

In the agentic era, defending against AI-accelerated adversaries, and securing AI systems themselves, requires operating at machine speed. The CrowdStrike 2026 Global Threat Report reflects this reality. It provides the...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 238




Lightsource bp Hitachi Solutions Drax Group plc Aldermore Group Stream British Land NATS Canaccord Genuity Group Inc Mayborn Group LACE Partners Legal & General E.ON UK NatWest Group Worldpay CrowdStrike AlixPartners London Stock Exchange Group GlaxoSmithKline plc Rolls-Royce